Commission makes official complaint to French:
This article was originally published in Clinica
The European Commission has officially complained to the French government over its intention to introduce more stringent regulatory requirements for high-risk devices. Six EU countries (see Clinica No 808, p 1) plus the European Commission have now told France its go-alone proposal for companies to notify them three months ahead of product launch would create a barrier to trade. The opposition forces France to delay introducing its new requirements until August 5.
You may also be interested in...
At the end of the Brexit transition period, the UK will be charting its own course through the often choppy seas of medicines regulation. While it plans to retain the existing EU rules that have been transposed into domestic legislation, it also wants the freedom to tailor its regulations in areas like clinical trials, advanced therapies and product labeling.
Health technology assessment body NICE is consulting on draft guidance that recommends Axonics' device for overactive bladder.